GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Wrnip1
|
ENSMUSG00000021400.6 | Werner helicase interacting protein 1 |
Mta3
|
ENSMUSG00000055817.11 | metastasis associated 3 |
Rcor1
|
ENSMUSG00000037896.11 | REST corepressor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Wrnip1 | mm10_v2_chr13_+_32802007_32802152 | -0.65 | 1.7e-05 | Click! |
Rcor1 | mm10_v2_chr12_+_111039334_111039400 | -0.42 | 1.0e-02 | Click! |
Mta3 | mm10_v2_chr17_+_83706137_83706169 | 0.41 | 1.2e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr9_+_111019284 | 19.68 |
ENSMUST00000035077.3
|
Ltf
|
lactotransferrin |
chr7_-_142657466 | 17.20 |
ENSMUST00000097936.2
ENSMUST00000000033.5 |
Igf2
|
insulin-like growth factor 2 |
chr11_+_87793722 | 16.57 |
ENSMUST00000143021.2
|
Mpo
|
myeloperoxidase |
chr7_+_117380937 | 12.85 |
ENSMUST00000032892.5
|
Xylt1
|
xylosyltransferase 1 |
chr7_-_142576492 | 12.84 |
ENSMUST00000140716.1
|
H19
|
H19 fetal liver mRNA |
chr7_-_45333754 | 12.80 |
ENSMUST00000042194.8
|
Trpm4
|
transient receptor potential cation channel, subfamily M, member 4 |
chr8_+_22974844 | 12.60 |
ENSMUST00000110688.2
ENSMUST00000121802.2 |
Ank1
|
ankyrin 1, erythroid |
chr11_+_87794206 | 12.14 |
ENSMUST00000121303.1
|
Mpo
|
myeloperoxidase |
chr11_+_87793470 | 11.99 |
ENSMUST00000020779.4
|
Mpo
|
myeloperoxidase |
chr2_+_84988194 | 11.82 |
ENSMUST00000028466.5
|
Prg3
|
proteoglycan 3 |
chr9_-_44288535 | 11.67 |
ENSMUST00000161354.1
|
Abcg4
|
ATP-binding cassette, sub-family G (WHITE), member 4 |
chrX_+_8271642 | 11.54 |
ENSMUST00000115590.1
|
Slc38a5
|
solute carrier family 38, member 5 |
chr16_+_17980565 | 11.52 |
ENSMUST00000075371.3
|
Vpreb2
|
pre-B lymphocyte gene 2 |
chr11_-_102107822 | 11.49 |
ENSMUST00000177304.1
ENSMUST00000017455.8 |
Pyy
|
peptide YY |
chr19_+_52264323 | 11.37 |
ENSMUST00000039652.4
|
Ins1
|
insulin I |
chr7_-_24760311 | 11.30 |
ENSMUST00000063956.5
|
Cd177
|
CD177 antigen |
chr4_+_141010644 | 11.23 |
ENSMUST00000071977.8
|
Mfap2
|
microfibrillar-associated protein 2 |
chr5_-_100159261 | 11.08 |
ENSMUST00000139520.1
|
Tmem150c
|
transmembrane protein 150C |
chr11_-_87875524 | 10.97 |
ENSMUST00000049768.3
|
Epx
|
eosinophil peroxidase |
chr11_-_69617879 | 10.29 |
ENSMUST00000005334.2
|
Shbg
|
sex hormone binding globulin |
chrX_-_136068236 | 10.26 |
ENSMUST00000049130.7
|
Bex2
|
brain expressed X-linked 2 |
chrX_+_8271381 | 10.20 |
ENSMUST00000033512.4
|
Slc38a5
|
solute carrier family 38, member 5 |
chr7_-_4752972 | 9.96 |
ENSMUST00000183971.1
ENSMUST00000182173.1 ENSMUST00000182738.1 ENSMUST00000184143.1 ENSMUST00000182111.1 ENSMUST00000182048.1 ENSMUST00000063324.7 |
Cox6b2
|
cytochrome c oxidase subunit VIb polypeptide 2 |
chr4_+_46039202 | 9.84 |
ENSMUST00000156200.1
|
Tmod1
|
tropomodulin 1 |
chr12_-_76709997 | 9.81 |
ENSMUST00000166101.1
|
Sptb
|
spectrin beta, erythrocytic |
chr10_+_79879614 | 9.80 |
ENSMUST00000006679.8
|
Prtn3
|
proteinase 3 |
chrX_+_8271133 | 9.72 |
ENSMUST00000127103.1
ENSMUST00000115591.1 |
Slc38a5
|
solute carrier family 38, member 5 |
chr16_-_18622403 | 9.62 |
ENSMUST00000167388.1
|
Gp1bb
|
glycoprotein Ib, beta polypeptide |
chr2_-_28621932 | 9.60 |
ENSMUST00000028156.7
ENSMUST00000164290.1 |
Gfi1b
|
growth factor independent 1B |
chr6_-_115762346 | 9.55 |
ENSMUST00000166254.1
ENSMUST00000170625.1 |
Tmem40
|
transmembrane protein 40 |
chr1_+_134182404 | 9.55 |
ENSMUST00000153856.1
ENSMUST00000082060.3 ENSMUST00000133701.1 ENSMUST00000132873.1 |
Chi3l1
|
chitinase 3-like 1 |
chr16_-_16869255 | 9.53 |
ENSMUST00000075017.4
|
Vpreb1
|
pre-B lymphocyte gene 1 |
chr3_+_108364882 | 9.51 |
ENSMUST00000090563.5
|
Mybphl
|
myosin binding protein H-like |
chr5_-_122050102 | 9.47 |
ENSMUST00000154139.1
|
Cux2
|
cut-like homeobox 2 |
chr2_-_28563362 | 9.31 |
ENSMUST00000028161.5
|
Cel
|
carboxyl ester lipase |
chr6_+_86078070 | 9.31 |
ENSMUST00000032069.5
|
Add2
|
adducin 2 (beta) |
chr11_-_102365111 | 9.27 |
ENSMUST00000006749.9
|
Slc4a1
|
solute carrier family 4 (anion exchanger), member 1 |
chr5_-_122049822 | 9.23 |
ENSMUST00000111752.3
|
Cux2
|
cut-like homeobox 2 |
chr11_+_95009852 | 9.01 |
ENSMUST00000055947.3
|
Samd14
|
sterile alpha motif domain containing 14 |
chr15_+_89334398 | 9.00 |
ENSMUST00000023282.2
|
Miox
|
myo-inositol oxygenase |
chr7_-_143460989 | 8.86 |
ENSMUST00000167912.1
ENSMUST00000037287.6 |
Cdkn1c
|
cyclin-dependent kinase inhibitor 1C (P57) |
chr5_-_107723954 | 8.84 |
ENSMUST00000165344.1
|
Gfi1
|
growth factor independent 1 |
chr10_-_19851459 | 8.81 |
ENSMUST00000059805.4
|
Slc35d3
|
solute carrier family 35, member D3 |
chrX_-_7964166 | 8.80 |
ENSMUST00000128449.1
|
Gata1
|
GATA binding protein 1 |
chr19_-_42431778 | 8.53 |
ENSMUST00000048630.6
|
Crtac1
|
cartilage acidic protein 1 |
chr12_+_24831583 | 8.52 |
ENSMUST00000110942.3
ENSMUST00000078902.6 |
Mboat2
|
membrane bound O-acyltransferase domain containing 2 |
chr2_+_127336152 | 8.44 |
ENSMUST00000028846.6
|
Dusp2
|
dual specificity phosphatase 2 |
chr10_+_79886302 | 8.43 |
ENSMUST00000046091.5
|
Elane
|
elastase, neutrophil expressed |
chr11_+_116531097 | 8.39 |
ENSMUST00000138840.1
|
Sphk1
|
sphingosine kinase 1 |
chr7_+_43797567 | 8.37 |
ENSMUST00000085461.2
|
Klk8
|
kallikrein related-peptidase 8 |
chr11_+_115877497 | 8.31 |
ENSMUST00000144032.1
|
Myo15b
|
myosin XVB |
chr7_-_142578093 | 8.19 |
ENSMUST00000149974.1
ENSMUST00000152754.1 |
H19
|
H19 fetal liver mRNA |
chr7_-_142578139 | 8.07 |
ENSMUST00000136359.1
|
H19
|
H19 fetal liver mRNA |
chr1_+_135799402 | 8.06 |
ENSMUST00000152208.1
ENSMUST00000152075.1 ENSMUST00000154463.1 ENSMUST00000139986.1 |
Tnni1
|
troponin I, skeletal, slow 1 |
chr11_-_12037391 | 7.99 |
ENSMUST00000093321.5
|
Grb10
|
growth factor receptor bound protein 10 |
chr19_+_54045182 | 7.97 |
ENSMUST00000036700.5
|
Adra2a
|
adrenergic receptor, alpha 2a |
chr1_-_119422239 | 7.94 |
ENSMUST00000038765.5
|
Inhbb
|
inhibin beta-B |
chr17_-_87797994 | 7.88 |
ENSMUST00000055221.7
|
Kcnk12
|
potassium channel, subfamily K, member 12 |
chr11_+_95010277 | 7.86 |
ENSMUST00000124735.1
|
Samd14
|
sterile alpha motif domain containing 14 |
chr2_-_91931675 | 7.85 |
ENSMUST00000111309.1
|
Mdk
|
midkine |
chr3_-_100489324 | 7.77 |
ENSMUST00000061455.8
|
Fam46c
|
family with sequence similarity 46, member C |
chr14_-_70635946 | 7.75 |
ENSMUST00000022695.9
|
Dmtn
|
dematin actin binding protein |
chr7_-_142666816 | 7.75 |
ENSMUST00000105935.1
|
Igf2
|
insulin-like growth factor 2 |
chr12_-_4841583 | 7.74 |
ENSMUST00000020964.5
|
Fkbp1b
|
FK506 binding protein 1b |
chr7_-_142679533 | 7.72 |
ENSMUST00000162317.1
ENSMUST00000125933.1 ENSMUST00000105931.1 ENSMUST00000105930.1 ENSMUST00000105933.1 ENSMUST00000105932.1 ENSMUST00000000220.2 |
Ins2
|
insulin II |
chr10_+_95417352 | 7.72 |
ENSMUST00000181781.1
|
5730420D15Rik
|
RIKEN cDNA 5730420D15 gene |
chr2_+_163054682 | 7.60 |
ENSMUST00000018005.3
|
Mybl2
|
myeloblastosis oncogene-like 2 |
chr11_-_46312220 | 7.53 |
ENSMUST00000129474.1
ENSMUST00000093166.4 ENSMUST00000165599.2 |
Cyfip2
|
cytoplasmic FMR1 interacting protein 2 |
chr11_+_116531744 | 7.48 |
ENSMUST00000106387.2
ENSMUST00000100201.3 |
Sphk1
|
sphingosine kinase 1 |
chr1_-_75133866 | 7.44 |
ENSMUST00000027405.4
|
Slc23a3
|
solute carrier family 23 (nucleobase transporters), member 3 |
chr19_-_24555819 | 7.44 |
ENSMUST00000112673.2
ENSMUST00000025800.8 |
Pip5k1b
|
phosphatidylinositol-4-phosphate 5-kinase, type 1 beta |
chr3_-_132950043 | 7.35 |
ENSMUST00000117164.1
ENSMUST00000093971.4 ENSMUST00000042729.9 ENSMUST00000042744.9 ENSMUST00000117811.1 |
Npnt
|
nephronectin |
chrX_-_73659724 | 7.35 |
ENSMUST00000114473.1
ENSMUST00000002087.7 |
Pnck
|
pregnancy upregulated non-ubiquitously expressed CaM kinase |
chr6_+_41392356 | 7.29 |
ENSMUST00000049079.7
|
Gm5771
|
predicted gene 5771 |
chr7_-_142659482 | 7.28 |
ENSMUST00000121128.1
|
Igf2
|
insulin-like growth factor 2 |
chr5_+_137288273 | 7.26 |
ENSMUST00000024099.4
ENSMUST00000085934.3 |
Ache
|
acetylcholinesterase |
chr1_+_42697146 | 7.24 |
ENSMUST00000054883.2
|
Pou3f3
|
POU domain, class 3, transcription factor 3 |
chr12_-_8539545 | 7.21 |
ENSMUST00000095863.3
ENSMUST00000165657.1 |
Slc7a15
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 15 |
chr4_-_137430517 | 7.20 |
ENSMUST00000102522.4
|
Cela3b
|
chymotrypsin-like elastase family, member 3B |
chr17_+_25298389 | 7.18 |
ENSMUST00000037453.2
|
Prss34
|
protease, serine, 34 |
chr5_+_90772435 | 7.17 |
ENSMUST00000031320.6
|
Pf4
|
platelet factor 4 |
chrX_-_7967817 | 7.09 |
ENSMUST00000033502.7
|
Gata1
|
GATA binding protein 1 |
chr14_-_60086832 | 7.08 |
ENSMUST00000080368.5
|
Atp8a2
|
ATPase, aminophospholipid transporter-like, class I, type 8A, member 2 |
chr7_+_142471838 | 7.05 |
ENSMUST00000038946.2
|
Lsp1
|
lymphocyte specific 1 |
chr2_-_35979624 | 7.05 |
ENSMUST00000028248.4
ENSMUST00000112976.2 |
Ttll11
|
tubulin tyrosine ligase-like family, member 11 |
chrX_-_136203637 | 7.01 |
ENSMUST00000151592.1
ENSMUST00000131510.1 ENSMUST00000066819.4 |
Tceal5
|
transcription elongation factor A (SII)-like 5 |
chr10_-_75940633 | 6.98 |
ENSMUST00000059658.4
|
Gm867
|
predicted gene 867 |
chr7_-_38107490 | 6.98 |
ENSMUST00000108023.3
|
Ccne1
|
cyclin E1 |
chrX_-_136215443 | 6.98 |
ENSMUST00000113120.1
ENSMUST00000113118.1 ENSMUST00000058125.8 |
Bex1
|
brain expressed gene 1 |
chr7_+_13278778 | 6.94 |
ENSMUST00000098814.4
ENSMUST00000146998.1 ENSMUST00000185145.1 |
Lig1
|
ligase I, DNA, ATP-dependent |
chr9_+_110419750 | 6.90 |
ENSMUST00000035061.6
|
Ngp
|
neutrophilic granule protein |
chr4_+_155962292 | 6.88 |
ENSMUST00000024338.4
|
Fam132a
|
family with sequence similarity 132, member A |
chr6_+_86628174 | 6.87 |
ENSMUST00000043400.6
|
Asprv1
|
aspartic peptidase, retroviral-like 1 |
chr2_-_131562283 | 6.86 |
ENSMUST00000103184.3
|
Adra1d
|
adrenergic receptor, alpha 1d |
chr11_+_70639118 | 6.86 |
ENSMUST00000055184.6
ENSMUST00000108551.2 |
Gp1ba
|
glycoprotein 1b, alpha polypeptide |
chr18_-_58209926 | 6.84 |
ENSMUST00000025497.6
|
Fbn2
|
fibrillin 2 |
chr6_+_134929089 | 6.84 |
ENSMUST00000183867.1
ENSMUST00000184991.1 ENSMUST00000183905.1 |
RP23-45G16.5
|
RP23-45G16.5 |
chr9_+_58014990 | 6.82 |
ENSMUST00000034874.7
|
Cyp11a1
|
cytochrome P450, family 11, subfamily a, polypeptide 1 |
chr9_+_45138437 | 6.80 |
ENSMUST00000060125.5
|
Scn4b
|
sodium channel, type IV, beta |
chr3_+_90669063 | 6.79 |
ENSMUST00000069927.8
|
S100a8
|
S100 calcium binding protein A8 (calgranulin A) |
chr9_-_44288332 | 6.73 |
ENSMUST00000161408.1
|
Abcg4
|
ATP-binding cassette, sub-family G (WHITE), member 4 |
chr6_+_41354105 | 6.67 |
ENSMUST00000072103.5
|
Try10
|
trypsin 10 |
chr1_+_135799833 | 6.64 |
ENSMUST00000148201.1
|
Tnni1
|
troponin I, skeletal, slow 1 |
chr3_+_108383829 | 6.63 |
ENSMUST00000090561.3
ENSMUST00000102629.1 ENSMUST00000128089.1 |
Psrc1
|
proline/serine-rich coiled-coil 1 |
chr17_-_26199008 | 6.63 |
ENSMUST00000142410.1
ENSMUST00000120333.1 ENSMUST00000039113.7 |
Pdia2
|
protein disulfide isomerase associated 2 |
chr17_+_28769307 | 6.59 |
ENSMUST00000004986.6
|
Mapk13
|
mitogen-activated protein kinase 13 |
chr16_-_10785525 | 6.58 |
ENSMUST00000038099.4
|
Socs1
|
suppressor of cytokine signaling 1 |
chr6_-_115758974 | 6.57 |
ENSMUST00000072933.6
|
Tmem40
|
transmembrane protein 40 |
chr17_+_48359891 | 6.57 |
ENSMUST00000024792.6
|
Treml1
|
triggering receptor expressed on myeloid cells-like 1 |
chr9_+_65587149 | 6.56 |
ENSMUST00000134538.1
ENSMUST00000136205.1 |
Pif1
|
PIF1 5'-to-3' DNA helicase homolog (S. cerevisiae) |
chr7_+_18884679 | 6.56 |
ENSMUST00000032573.6
|
Pglyrp1
|
peptidoglycan recognition protein 1 |
chr11_-_102469839 | 6.55 |
ENSMUST00000103086.3
|
Itga2b
|
integrin alpha 2b |
chr6_+_41521782 | 6.54 |
ENSMUST00000070380.4
|
Prss2
|
protease, serine, 2 |
chr8_-_122460666 | 6.51 |
ENSMUST00000006762.5
|
Snai3
|
snail homolog 3 (Drosophila) |
chr5_+_142702091 | 6.48 |
ENSMUST00000058418.7
|
Slc29a4
|
solute carrier family 29 (nucleoside transporters), member 4 |
chr4_+_49059256 | 6.43 |
ENSMUST00000076670.2
|
E130309F12Rik
|
RIKEN cDNA E130309F12 gene |
chr7_+_24777172 | 6.41 |
ENSMUST00000038069.7
|
Ceacam10
|
carcinoembryonic antigen-related cell adhesion molecule 10 |
chr2_+_148798785 | 6.41 |
ENSMUST00000028931.3
ENSMUST00000109947.1 |
Cst8
|
cystatin 8 (cystatin-related epididymal spermatogenic) |
chr7_+_28863831 | 6.31 |
ENSMUST00000138272.1
|
Lgals7
|
lectin, galactose binding, soluble 7 |
chr6_-_41704339 | 6.30 |
ENSMUST00000031899.8
|
Kel
|
Kell blood group |
chr11_-_107716517 | 6.30 |
ENSMUST00000021065.5
|
Cacng1
|
calcium channel, voltage-dependent, gamma subunit 1 |
chrX_+_73639414 | 6.26 |
ENSMUST00000019701.8
|
Dusp9
|
dual specificity phosphatase 9 |
chr3_-_98339921 | 6.26 |
ENSMUST00000065793.5
|
Phgdh
|
3-phosphoglycerate dehydrogenase |
chr1_+_134182150 | 6.21 |
ENSMUST00000156873.1
|
Chi3l1
|
chitinase 3-like 1 |
chr7_-_142661305 | 6.20 |
ENSMUST00000105936.1
|
Igf2
|
insulin-like growth factor 2 |
chrX_+_135993820 | 6.19 |
ENSMUST00000058119.7
|
Arxes2
|
adipocyte-related X-chromosome expressed sequence 2 |
chr4_-_116123618 | 6.19 |
ENSMUST00000102704.3
ENSMUST00000102705.3 |
Rad54l
|
RAD54 like (S. cerevisiae) |
chr6_+_99692679 | 6.18 |
ENSMUST00000101122.1
|
Gpr27
|
G protein-coupled receptor 27 |
chr7_+_30763750 | 6.14 |
ENSMUST00000165887.1
ENSMUST00000085691.4 ENSMUST00000085688.4 ENSMUST00000054427.6 |
Dmkn
|
dermokine |
chr4_+_115057683 | 6.14 |
ENSMUST00000161601.1
|
Tal1
|
T cell acute lymphocytic leukemia 1 |
chr10_-_128401218 | 6.14 |
ENSMUST00000042666.5
|
Slc39a5
|
solute carrier family 39 (metal ion transporter), member 5 |
chr11_+_44617310 | 6.12 |
ENSMUST00000081265.5
ENSMUST00000101326.3 ENSMUST00000109268.1 |
Ebf1
|
early B cell factor 1 |
chr2_-_91931696 | 6.08 |
ENSMUST00000090602.5
|
Mdk
|
midkine |
chr10_+_75564086 | 6.06 |
ENSMUST00000141062.1
ENSMUST00000152657.1 |
Ggt1
|
gamma-glutamyltransferase 1 |
chr2_-_91931774 | 6.03 |
ENSMUST00000069423.6
|
Mdk
|
midkine |
chr13_+_18948344 | 5.98 |
ENSMUST00000003345.7
|
Amph
|
amphiphysin |
chr2_+_164948219 | 5.98 |
ENSMUST00000017881.2
|
Mmp9
|
matrix metallopeptidase 9 |
chr4_-_68954351 | 5.98 |
ENSMUST00000030036.5
|
Brinp1
|
bone morphogenic protein/retinoic acid inducible neural specific 1 |
chr7_-_127051948 | 5.94 |
ENSMUST00000051122.5
|
Zg16
|
zymogen granule protein 16 |
chr2_+_112239468 | 5.89 |
ENSMUST00000028554.3
|
Lpcat4
|
lysophosphatidylcholine acyltransferase 4 |
chr2_-_152415044 | 5.88 |
ENSMUST00000099207.3
|
Zcchc3
|
zinc finger, CCHC domain containing 3 |
chr6_+_41458923 | 5.88 |
ENSMUST00000031910.7
|
Prss1
|
protease, serine, 1 (trypsin 1) |
chr8_+_72761868 | 5.86 |
ENSMUST00000058099.8
|
F2rl3
|
coagulation factor II (thrombin) receptor-like 3 |
chr15_-_101491509 | 5.85 |
ENSMUST00000023718.7
|
5430421N21Rik
|
RIKEN cDNA 5430421N21 gene |
chr1_+_40084764 | 5.83 |
ENSMUST00000027243.7
|
Il1r2
|
interleukin 1 receptor, type II |
chr11_+_115887601 | 5.82 |
ENSMUST00000167507.2
|
Myo15b
|
myosin XVB |
chr6_+_29396576 | 5.79 |
ENSMUST00000115275.1
|
Ccdc136
|
coiled-coil domain containing 136 |
chrX_-_52613936 | 5.77 |
ENSMUST00000114857.1
|
Gpc3
|
glypican 3 |
chr2_+_91035613 | 5.77 |
ENSMUST00000111445.3
ENSMUST00000111446.3 ENSMUST00000050323.5 |
Rapsn
|
receptor-associated protein of the synapse |
chr11_+_58918004 | 5.77 |
ENSMUST00000108818.3
ENSMUST00000020792.5 |
Btnl10
|
butyrophilin-like 10 |
chr19_+_6084983 | 5.75 |
ENSMUST00000025704.2
|
Cdca5
|
cell division cycle associated 5 |
chr11_-_102088471 | 5.72 |
ENSMUST00000017458.4
|
Mpp2
|
membrane protein, palmitoylated 2 (MAGUK p55 subfamily member 2) |
chrX_-_8145713 | 5.72 |
ENSMUST00000115615.2
ENSMUST00000115616.1 ENSMUST00000115621.2 |
Rbm3
|
RNA binding motif protein 3 |
chrX_-_7978027 | 5.70 |
ENSMUST00000125418.1
|
Gata1
|
GATA binding protein 1 |
chr11_+_32286946 | 5.70 |
ENSMUST00000101387.3
|
Hbq1b
|
hemoglobin, theta 1B |
chr6_+_122513583 | 5.68 |
ENSMUST00000032210.7
ENSMUST00000148517.1 |
Mfap5
|
microfibrillar associated protein 5 |
chr7_-_120982260 | 5.67 |
ENSMUST00000033169.8
|
Cdr2
|
cerebellar degeneration-related 2 |
chrX_+_136270253 | 5.66 |
ENSMUST00000178632.1
ENSMUST00000053540.4 |
Ngfrap1
|
nerve growth factor receptor (TNFRSF16) associated protein 1 |
chr8_-_123859423 | 5.66 |
ENSMUST00000034452.5
|
Ccsap
|
centriole, cilia and spindle associated protein |
chr9_-_44288131 | 5.62 |
ENSMUST00000160384.1
|
Abcg4
|
ATP-binding cassette, sub-family G (WHITE), member 4 |
chr17_+_25366550 | 5.60 |
ENSMUST00000069616.7
|
Tpsb2
|
tryptase beta 2 |
chr5_+_66676098 | 5.60 |
ENSMUST00000031131.9
|
Uchl1
|
ubiquitin carboxy-terminal hydrolase L1 |
chr5_+_33658567 | 5.58 |
ENSMUST00000114426.3
|
Tacc3
|
transforming, acidic coiled-coil containing protein 3 |
chr11_+_7197780 | 5.57 |
ENSMUST00000020704.7
|
Igfbp1
|
insulin-like growth factor binding protein 1 |
chr4_+_115057410 | 5.56 |
ENSMUST00000136946.1
|
Tal1
|
T cell acute lymphocytic leukemia 1 |
chr9_+_8544196 | 5.56 |
ENSMUST00000050433.6
|
Trpc6
|
transient receptor potential cation channel, subfamily C, member 6 |
chr17_-_35066170 | 5.56 |
ENSMUST00000174190.1
ENSMUST00000097337.1 |
AU023871
|
expressed sequence AU023871 |
chr2_+_156840077 | 5.53 |
ENSMUST00000081335.6
ENSMUST00000073352.3 |
Tgif2
|
TGFB-induced factor homeobox 2 |
chr9_+_65587187 | 5.52 |
ENSMUST00000047099.5
ENSMUST00000131483.1 ENSMUST00000141046.1 |
Pif1
|
PIF1 5'-to-3' DNA helicase homolog (S. cerevisiae) |
chr19_+_7268296 | 5.49 |
ENSMUST00000066646.4
|
Rcor2
|
REST corepressor 2 |
chr14_-_70630149 | 5.48 |
ENSMUST00000022694.9
|
Dmtn
|
dematin actin binding protein |
chr15_-_85581809 | 5.47 |
ENSMUST00000023015.7
|
Wnt7b
|
wingless-related MMTV integration site 7B |
chrX_-_8145679 | 5.45 |
ENSMUST00000115619.1
ENSMUST00000115617.3 ENSMUST00000040010.3 |
Rbm3
|
RNA binding motif protein 3 |
chr8_-_105471481 | 5.45 |
ENSMUST00000014990.6
|
Tppp3
|
tubulin polymerization-promoting protein family member 3 |
chr10_-_84533968 | 5.42 |
ENSMUST00000167671.1
|
Ckap4
|
cytoskeleton-associated protein 4 |
chr14_+_80000292 | 5.42 |
ENSMUST00000088735.3
|
Olfm4
|
olfactomedin 4 |
chr10_+_121033960 | 5.40 |
ENSMUST00000020439.4
ENSMUST00000175867.1 |
Wif1
|
Wnt inhibitory factor 1 |
chr3_-_54915867 | 5.39 |
ENSMUST00000070342.3
|
Sertm1
|
serine rich and transmembrane domain containing 1 |
chr3_-_90695706 | 5.37 |
ENSMUST00000069960.5
ENSMUST00000117167.1 |
S100a9
|
S100 calcium binding protein A9 (calgranulin B) |
chr3_-_152166230 | 5.36 |
ENSMUST00000046614.9
|
Gipc2
|
GIPC PDZ domain containing family, member 2 |
chr6_+_115774538 | 5.36 |
ENSMUST00000075995.5
|
Cand2
|
cullin-associated and neddylation-dissociated 2 (putative) |
chr19_-_45816007 | 5.36 |
ENSMUST00000079431.3
ENSMUST00000026247.6 ENSMUST00000162528.2 |
Kcnip2
|
Kv channel-interacting protein 2 |
chr2_+_84980458 | 5.35 |
ENSMUST00000028467.5
|
Prg2
|
proteoglycan 2, bone marrow |
chr9_+_65101453 | 5.35 |
ENSMUST00000077696.6
ENSMUST00000035499.4 ENSMUST00000166273.1 |
Igdcc4
|
immunoglobulin superfamily, DCC subclass, member 4 |
chr15_-_82212796 | 5.33 |
ENSMUST00000179269.1
|
AI848285
|
expressed sequence AI848285 |
chr12_+_113185877 | 5.32 |
ENSMUST00000058491.6
|
Tmem121
|
transmembrane protein 121 |
chr14_-_56085214 | 5.30 |
ENSMUST00000015594.7
|
Mcpt8
|
mast cell protease 8 |
chr5_-_107726017 | 5.29 |
ENSMUST00000159263.2
|
Gfi1
|
growth factor independent 1 |
chr6_+_87778084 | 5.28 |
ENSMUST00000032133.3
|
Gp9
|
glycoprotein 9 (platelet) |
chr17_-_29237759 | 5.28 |
ENSMUST00000137727.1
ENSMUST00000024805.7 |
Cpne5
|
copine V |
chr8_+_83955507 | 5.27 |
ENSMUST00000005607.8
|
Asf1b
|
ASF1 anti-silencing function 1 homolog B (S. cerevisiae) |
chr6_+_29396665 | 5.26 |
ENSMUST00000096084.5
|
Ccdc136
|
coiled-coil domain containing 136 |
chr2_+_145167706 | 5.26 |
ENSMUST00000110007.1
|
Slc24a3
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 3 |
chr17_-_25433775 | 5.24 |
ENSMUST00000159610.1
ENSMUST00000159048.1 ENSMUST00000078496.5 |
Cacna1h
|
calcium channel, voltage-dependent, T type, alpha 1H subunit |
chr8_+_93810832 | 5.23 |
ENSMUST00000034198.8
ENSMUST00000125716.1 |
Gnao1
|
guanine nucleotide binding protein, alpha O |
chr5_+_33658550 | 5.21 |
ENSMUST00000152847.1
|
Tacc3
|
transforming, acidic coiled-coil containing protein 3 |
chr9_-_109849440 | 5.19 |
ENSMUST00000112022.2
|
Camp
|
cathelicidin antimicrobial peptide |
chr11_+_117849223 | 5.19 |
ENSMUST00000081387.4
|
Birc5
|
baculoviral IAP repeat-containing 5 |
chr10_+_75571522 | 5.17 |
ENSMUST00000143226.1
ENSMUST00000124259.1 |
Ggt1
|
gamma-glutamyltransferase 1 |
chr4_+_100776664 | 5.17 |
ENSMUST00000030257.8
ENSMUST00000097955.2 |
Cachd1
|
cache domain containing 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.6 | 40.7 | GO:0002148 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
7.2 | 21.6 | GO:0030221 | basophil differentiation(GO:0030221) |
5.6 | 45.0 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
5.5 | 16.6 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
5.4 | 16.3 | GO:0002215 | defense response to nematode(GO:0002215) |
5.0 | 15.1 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
4.2 | 12.6 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
4.2 | 12.5 | GO:0060217 | hemangioblast cell differentiation(GO:0060217) |
3.8 | 7.7 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
3.8 | 7.5 | GO:0031938 | regulation of chromatin silencing at telomere(GO:0031938) |
3.8 | 3.8 | GO:2000277 | positive regulation of oxidative phosphorylation uncoupler activity(GO:2000277) |
3.7 | 22.1 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
3.6 | 10.9 | GO:0070488 | neutrophil aggregation(GO:0070488) |
3.6 | 28.4 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
3.5 | 10.6 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
3.5 | 20.7 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
3.4 | 3.4 | GO:0007521 | muscle cell fate determination(GO:0007521) |
3.3 | 13.3 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
3.2 | 9.7 | GO:0072299 | negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
3.2 | 16.1 | GO:0072236 | metanephric loop of Henle development(GO:0072236) |
3.2 | 18.9 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
3.1 | 12.5 | GO:0045575 | basophil activation(GO:0045575) |
3.1 | 9.4 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
3.1 | 15.5 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
3.1 | 3.1 | GO:0070099 | regulation of chemokine-mediated signaling pathway(GO:0070099) |
3.1 | 12.4 | GO:1904800 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) |
3.0 | 14.9 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
2.9 | 14.6 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
2.9 | 8.8 | GO:0032690 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
2.9 | 8.8 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
2.8 | 8.5 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
2.8 | 2.8 | GO:0060022 | hard palate development(GO:0060022) |
2.8 | 11.2 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
2.8 | 13.9 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
2.7 | 8.2 | GO:0071918 | urea transmembrane transport(GO:0071918) |
2.6 | 18.5 | GO:0030421 | defecation(GO:0030421) |
2.6 | 2.6 | GO:0009414 | response to water deprivation(GO:0009414) |
2.6 | 7.7 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
2.6 | 10.3 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
2.5 | 10.2 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
2.5 | 2.5 | GO:0072166 | posterior mesonephric tubule development(GO:0072166) |
2.5 | 7.6 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
2.5 | 7.4 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
2.5 | 7.4 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
2.4 | 2.4 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
2.4 | 2.4 | GO:1905204 | regulation of connective tissue replacement(GO:1905203) negative regulation of connective tissue replacement(GO:1905204) |
2.4 | 19.2 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
2.4 | 7.1 | GO:0072382 | minus-end-directed vesicle transport along microtubule(GO:0072382) |
2.3 | 30.2 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
2.3 | 7.0 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
2.3 | 6.9 | GO:0051714 | regulation of cytolysis in other organism(GO:0051710) positive regulation of cytolysis in other organism(GO:0051714) |
2.3 | 9.2 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
2.3 | 9.2 | GO:0051944 | positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
2.3 | 9.1 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
2.3 | 40.9 | GO:0015816 | glycine transport(GO:0015816) |
2.3 | 18.0 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
2.2 | 11.2 | GO:0071105 | response to interleukin-11(GO:0071105) |
2.2 | 35.6 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
2.2 | 6.6 | GO:1903367 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
2.2 | 6.5 | GO:0031283 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
2.2 | 8.6 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
2.1 | 15.0 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
2.1 | 4.3 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
2.1 | 6.4 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
2.1 | 6.4 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
2.1 | 6.4 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
2.1 | 8.4 | GO:0015825 | L-serine transport(GO:0015825) |
2.1 | 4.2 | GO:0070560 | protein secretion by platelet(GO:0070560) |
2.1 | 2.1 | GO:1901608 | regulation of vesicle transport along microtubule(GO:1901608) |
2.1 | 8.2 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
2.0 | 8.2 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
2.0 | 6.0 | GO:0014064 | positive regulation of serotonin secretion(GO:0014064) |
2.0 | 4.0 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
2.0 | 10.0 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
2.0 | 10.0 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
2.0 | 7.9 | GO:1903575 | cornified envelope assembly(GO:1903575) |
2.0 | 2.0 | GO:0033624 | negative regulation of integrin activation(GO:0033624) |
2.0 | 7.9 | GO:0048769 | sarcomerogenesis(GO:0048769) |
1.9 | 9.7 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.9 | 1.9 | GO:0072284 | metanephric S-shaped body morphogenesis(GO:0072284) |
1.9 | 9.6 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
1.9 | 9.6 | GO:0035989 | tendon development(GO:0035989) |
1.9 | 3.8 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
1.9 | 5.7 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
1.9 | 1.9 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
1.9 | 5.6 | GO:0061743 | motor learning(GO:0061743) |
1.9 | 5.6 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
1.8 | 5.5 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
1.8 | 7.4 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
1.8 | 5.5 | GO:0045004 | DNA replication proofreading(GO:0045004) |
1.8 | 5.5 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
1.8 | 1.8 | GO:1904008 | response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
1.8 | 5.5 | GO:1990523 | bone regeneration(GO:1990523) |
1.8 | 7.3 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
1.8 | 3.6 | GO:0060031 | mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
1.8 | 10.8 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
1.8 | 7.2 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
1.8 | 9.0 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
1.8 | 7.2 | GO:0015840 | urea transport(GO:0015840) |
1.8 | 8.9 | GO:0070944 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) |
1.8 | 5.3 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
1.8 | 1.8 | GO:0035854 | eosinophil fate commitment(GO:0035854) |
1.8 | 7.1 | GO:0040038 | polar body extrusion after meiotic divisions(GO:0040038) |
1.8 | 5.3 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
1.8 | 7.0 | GO:0060032 | notochord regression(GO:0060032) |
1.7 | 5.2 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
1.7 | 3.5 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
1.7 | 5.1 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
1.7 | 17.1 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
1.7 | 5.1 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
1.7 | 10.2 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
1.7 | 17.0 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
1.7 | 8.5 | GO:0097167 | circadian regulation of translation(GO:0097167) |
1.7 | 1.7 | GO:0021623 | oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
1.7 | 11.6 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
1.6 | 4.9 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
1.6 | 6.6 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
1.6 | 3.3 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
1.6 | 4.9 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
1.6 | 6.5 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
1.6 | 4.8 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
1.6 | 9.6 | GO:1900204 | pronephric field specification(GO:0039003) pattern specification involved in pronephros development(GO:0039017) kidney field specification(GO:0072004) regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072304) negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072305) apoptotic process involved in metanephric collecting duct development(GO:1900204) apoptotic process involved in metanephric nephron tubule development(GO:1900205) regulation of apoptotic process involved in metanephric collecting duct development(GO:1900214) negative regulation of apoptotic process involved in metanephric collecting duct development(GO:1900215) regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900217) negative regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900218) mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:1901147) regulation of metanephric DCT cell differentiation(GO:2000592) positive regulation of metanephric DCT cell differentiation(GO:2000594) |
1.6 | 4.7 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
1.6 | 1.6 | GO:0035566 | regulation of metanephros size(GO:0035566) |
1.6 | 3.2 | GO:0002582 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
1.6 | 6.3 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
1.6 | 1.6 | GO:2000388 | positive regulation of ovarian follicle development(GO:2000386) regulation of antral ovarian follicle growth(GO:2000387) positive regulation of antral ovarian follicle growth(GO:2000388) |
1.6 | 1.6 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
1.6 | 4.7 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
1.6 | 4.7 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
1.5 | 6.2 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
1.5 | 6.2 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
1.5 | 21.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
1.5 | 3.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
1.5 | 1.5 | GO:0072235 | metanephric part of ureteric bud development(GO:0035502) distal convoluted tubule development(GO:0072025) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) |
1.5 | 6.1 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) regulation of vascular wound healing(GO:0061043) |
1.5 | 4.5 | GO:0050929 | corticospinal neuron axon guidance through spinal cord(GO:0021972) positive regulation of negative chemotaxis(GO:0050924) induction of negative chemotaxis(GO:0050929) negative regulation of mononuclear cell migration(GO:0071676) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
1.5 | 7.5 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
1.5 | 3.0 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
1.5 | 4.5 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
1.5 | 6.0 | GO:0031296 | B cell costimulation(GO:0031296) |
1.5 | 3.0 | GO:0072162 | metanephric mesenchymal cell differentiation(GO:0072162) |
1.5 | 11.9 | GO:0030220 | platelet formation(GO:0030220) |
1.5 | 1.5 | GO:0061438 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) |
1.5 | 16.2 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
1.5 | 4.4 | GO:0060166 | olfactory pit development(GO:0060166) |
1.5 | 4.4 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
1.5 | 23.5 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
1.5 | 5.9 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
1.5 | 1.5 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
1.4 | 21.7 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
1.4 | 1.4 | GO:0090314 | positive regulation of protein targeting to membrane(GO:0090314) |
1.4 | 5.8 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
1.4 | 1.4 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
1.4 | 2.9 | GO:0071663 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
1.4 | 8.6 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
1.4 | 1.4 | GO:0032808 | lacrimal gland development(GO:0032808) |
1.4 | 4.3 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
1.4 | 1.4 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
1.4 | 2.8 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
1.4 | 4.2 | GO:0071314 | cellular response to cocaine(GO:0071314) |
1.4 | 9.8 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
1.4 | 7.0 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
1.4 | 4.2 | GO:2000768 | glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
1.4 | 7.0 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
1.4 | 15.3 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
1.4 | 6.9 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
1.4 | 5.5 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.4 | 2.7 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
1.4 | 12.2 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
1.4 | 10.9 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
1.3 | 8.1 | GO:0031133 | regulation of axon diameter(GO:0031133) |
1.3 | 1.3 | GO:0015793 | glycerol transport(GO:0015793) |
1.3 | 2.7 | GO:0072053 | renal inner medulla development(GO:0072053) |
1.3 | 1.3 | GO:0071727 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
1.3 | 25.4 | GO:0007614 | short-term memory(GO:0007614) |
1.3 | 5.3 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
1.3 | 4.0 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
1.3 | 1.3 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
1.3 | 2.7 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
1.3 | 6.6 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
1.3 | 2.6 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
1.3 | 1.3 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
1.3 | 10.5 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
1.3 | 3.9 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
1.3 | 10.4 | GO:0015671 | oxygen transport(GO:0015671) |
1.3 | 6.5 | GO:1905171 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
1.3 | 3.9 | GO:0036292 | DNA rewinding(GO:0036292) |
1.3 | 3.9 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
1.3 | 6.5 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
1.3 | 3.9 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
1.3 | 13.0 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
1.3 | 9.1 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
1.3 | 7.8 | GO:0001866 | NK T cell proliferation(GO:0001866) |
1.3 | 3.9 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
1.3 | 2.6 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
1.3 | 2.6 | GO:0051795 | positive regulation of catagen(GO:0051795) |
1.3 | 12.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
1.3 | 2.6 | GO:0033058 | directional locomotion(GO:0033058) |
1.3 | 2.5 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
1.3 | 7.6 | GO:0060023 | soft palate development(GO:0060023) |
1.3 | 1.3 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
1.3 | 7.6 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
1.3 | 3.8 | GO:0002343 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
1.3 | 5.0 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
1.3 | 22.6 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
1.3 | 2.5 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
1.3 | 5.0 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
1.2 | 3.7 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
1.2 | 3.7 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
1.2 | 19.8 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
1.2 | 1.2 | GO:0051794 | regulation of catagen(GO:0051794) |
1.2 | 6.2 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
1.2 | 2.5 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
1.2 | 1.2 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
1.2 | 1.2 | GO:0032329 | serine transport(GO:0032329) |
1.2 | 1.2 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
1.2 | 3.7 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
1.2 | 3.7 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
1.2 | 3.7 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
1.2 | 2.4 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
1.2 | 3.6 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
1.2 | 3.6 | GO:0071846 | actin filament debranching(GO:0071846) |
1.2 | 1.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
1.2 | 4.8 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
1.2 | 2.4 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
1.2 | 3.6 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
1.2 | 2.4 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
1.2 | 3.6 | GO:0002030 | inhibitory G-protein coupled receptor phosphorylation(GO:0002030) |
1.2 | 3.5 | GO:0001928 | regulation of exocyst assembly(GO:0001928) |
1.2 | 3.5 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
1.2 | 3.5 | GO:0051934 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) |
1.2 | 9.4 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
1.2 | 2.3 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
1.2 | 3.5 | GO:0051466 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
1.2 | 3.5 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
1.2 | 4.6 | GO:0060242 | contact inhibition(GO:0060242) |
1.2 | 1.2 | GO:1990773 | regulation of matrix metallopeptidase secretion(GO:1904464) matrix metallopeptidase secretion(GO:1990773) |
1.1 | 1.1 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
1.1 | 4.6 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
1.1 | 1.1 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
1.1 | 1.1 | GO:0031335 | regulation of sulfur amino acid metabolic process(GO:0031335) |
1.1 | 1.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
1.1 | 4.6 | GO:0030070 | insulin processing(GO:0030070) |
1.1 | 1.1 | GO:0090172 | microtubule cytoskeleton organization involved in homologous chromosome segregation(GO:0090172) |
1.1 | 4.5 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
1.1 | 9.0 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
1.1 | 21.4 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
1.1 | 3.4 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
1.1 | 6.7 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
1.1 | 4.5 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
1.1 | 1.1 | GO:0099552 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
1.1 | 3.3 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
1.1 | 4.4 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
1.1 | 7.7 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
1.1 | 3.3 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
1.1 | 7.6 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
1.1 | 10.9 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
1.1 | 2.2 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
1.1 | 3.3 | GO:1902870 | negative regulation of neural retina development(GO:0061076) negative regulation of retina development in camera-type eye(GO:1902867) negative regulation of amacrine cell differentiation(GO:1902870) |
1.1 | 4.3 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
1.1 | 4.3 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
1.1 | 5.4 | GO:0070586 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) cell-cell adhesion involved in gastrulation(GO:0070586) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
1.1 | 9.7 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
1.1 | 2.1 | GO:0015675 | nickel cation transport(GO:0015675) |
1.1 | 3.2 | GO:0035702 | monocyte homeostasis(GO:0035702) |
1.1 | 4.3 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
1.1 | 2.1 | GO:2000568 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
1.1 | 3.2 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
1.1 | 1.1 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
1.1 | 3.2 | GO:0072049 | comma-shaped body morphogenesis(GO:0072049) |
1.0 | 1.0 | GO:2000328 | regulation of T-helper 17 cell lineage commitment(GO:2000328) |
1.0 | 4.2 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
1.0 | 1.0 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
1.0 | 2.1 | GO:2001201 | regulation of transforming growth factor-beta secretion(GO:2001201) |
1.0 | 7.2 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
1.0 | 5.2 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
1.0 | 2.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
1.0 | 3.1 | GO:0046144 | D-serine catabolic process(GO:0036088) D-alanine family amino acid metabolic process(GO:0046144) D-alanine metabolic process(GO:0046436) D-alanine catabolic process(GO:0055130) |
1.0 | 2.1 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
1.0 | 15.4 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
1.0 | 4.1 | GO:1900120 | regulation of receptor binding(GO:1900120) |
1.0 | 5.1 | GO:0032901 | positive regulation of neurotrophin production(GO:0032901) |
1.0 | 8.1 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
1.0 | 2.0 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
1.0 | 2.0 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
1.0 | 4.0 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
1.0 | 2.0 | GO:0010958 | regulation of amino acid import(GO:0010958) |
1.0 | 1.0 | GO:0006272 | leading strand elongation(GO:0006272) |
1.0 | 5.0 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
1.0 | 2.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
1.0 | 3.0 | GO:0072720 | response to dithiothreitol(GO:0072720) |
1.0 | 6.9 | GO:0051013 | microtubule severing(GO:0051013) |
1.0 | 5.0 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
1.0 | 9.9 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
1.0 | 3.0 | GO:0035926 | chemokine (C-C motif) ligand 2 secretion(GO:0035926) regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
1.0 | 3.9 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
1.0 | 1.0 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) |
1.0 | 2.9 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
1.0 | 2.9 | GO:0044849 | estrous cycle(GO:0044849) |
1.0 | 2.9 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
1.0 | 7.8 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
1.0 | 4.9 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
1.0 | 1.9 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
1.0 | 1.0 | GO:1904170 | regulation of bleb assembly(GO:1904170) |
1.0 | 6.7 | GO:0046208 | spermine catabolic process(GO:0046208) |
1.0 | 13.3 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
1.0 | 1.0 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.9 | 2.8 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
0.9 | 0.9 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.9 | 1.9 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.9 | 2.8 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.9 | 2.8 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.9 | 1.9 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.9 | 5.7 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.9 | 5.7 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.9 | 3.8 | GO:0003192 | mitral valve formation(GO:0003192) |
0.9 | 3.8 | GO:0006868 | glutamine transport(GO:0006868) |
0.9 | 5.6 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.9 | 3.7 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.9 | 7.5 | GO:0015074 | DNA integration(GO:0015074) |
0.9 | 0.9 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.9 | 14.9 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.9 | 6.5 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.9 | 11.1 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.9 | 34.2 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.9 | 8.3 | GO:0002432 | granuloma formation(GO:0002432) |
0.9 | 5.5 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.9 | 11.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.9 | 12.8 | GO:0051451 | myoblast migration(GO:0051451) |
0.9 | 4.6 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.9 | 2.7 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.9 | 0.9 | GO:0007356 | thorax and anterior abdomen determination(GO:0007356) |
0.9 | 5.4 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.9 | 0.9 | GO:1904057 | negative regulation of sensory perception of pain(GO:1904057) |
0.9 | 3.6 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.9 | 0.9 | GO:0035799 | ureter maturation(GO:0035799) |
0.9 | 2.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.9 | 16.9 | GO:0001675 | acrosome assembly(GO:0001675) |
0.9 | 2.7 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.9 | 3.6 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.9 | 2.7 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
0.9 | 7.1 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.9 | 2.6 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.9 | 6.2 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.9 | 2.6 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.9 | 2.6 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.9 | 4.4 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.9 | 0.9 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.9 | 4.4 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.9 | 2.6 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.9 | 29.6 | GO:0048821 | erythrocyte development(GO:0048821) |
0.9 | 7.8 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.9 | 2.6 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.9 | 2.6 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.9 | 10.4 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.9 | 3.5 | GO:1901374 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.9 | 5.2 | GO:0007412 | axon target recognition(GO:0007412) |
0.9 | 7.8 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.9 | 39.6 | GO:0051693 | actin filament capping(GO:0051693) |
0.9 | 3.4 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.9 | 4.3 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.9 | 0.9 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.9 | 1.7 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
0.8 | 2.5 | GO:0036269 | swimming behavior(GO:0036269) |
0.8 | 4.2 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.8 | 7.6 | GO:0071231 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
0.8 | 2.5 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.8 | 3.4 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.8 | 1.7 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.8 | 6.7 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.8 | 4.2 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.8 | 2.5 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.8 | 4.1 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
0.8 | 4.9 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) negative regulation of DNA damage checkpoint(GO:2000002) |
0.8 | 1.6 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.8 | 4.9 | GO:0006116 | NADH oxidation(GO:0006116) |
0.8 | 1.6 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.8 | 0.8 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.8 | 1.6 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.8 | 6.5 | GO:0006735 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.8 | 5.7 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.8 | 2.4 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.8 | 0.8 | GO:0033082 | regulation of extrathymic T cell differentiation(GO:0033082) |
0.8 | 6.4 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.8 | 5.6 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.8 | 0.8 | GO:2000412 | positive regulation of thymocyte migration(GO:2000412) |
0.8 | 3.2 | GO:0002838 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.8 | 0.8 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.8 | 0.8 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.8 | 16.7 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.8 | 6.4 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.8 | 0.8 | GO:0018307 | enzyme active site formation(GO:0018307) |
0.8 | 6.3 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.8 | 1.6 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.8 | 7.9 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.8 | 3.9 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.8 | 10.9 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.8 | 1.6 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.8 | 2.3 | GO:0052203 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.8 | 3.9 | GO:1904925 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
0.8 | 0.8 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.8 | 1.5 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.8 | 3.1 | GO:0072738 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
0.8 | 3.8 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.8 | 2.3 | GO:0015811 | L-cystine transport(GO:0015811) |
0.8 | 3.1 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.8 | 3.1 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.8 | 9.2 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.8 | 1.5 | GO:0055096 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.8 | 5.3 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.8 | 5.3 | GO:0086011 | membrane repolarization during action potential(GO:0086011) |
0.8 | 4.5 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.8 | 2.3 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.8 | 1.5 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.8 | 4.5 | GO:0007144 | female meiosis I(GO:0007144) |
0.8 | 3.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.8 | 1.5 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.8 | 3.0 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.7 | 1.5 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.7 | 2.2 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.7 | 0.7 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.7 | 0.7 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.7 | 4.4 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.7 | 0.7 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
0.7 | 3.0 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.7 | 4.4 | GO:1903182 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
0.7 | 1.5 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
0.7 | 2.9 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.7 | 2.9 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.7 | 1.5 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.7 | 2.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.7 | 3.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.7 | 2.2 | GO:1902913 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.7 | 1.5 | GO:0006848 | pyruvate transport(GO:0006848) |
0.7 | 2.2 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.7 | 0.7 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.7 | 4.3 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
0.7 | 2.2 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.7 | 1.4 | GO:1900244 | positive regulation of synaptic vesicle endocytosis(GO:1900244) |
0.7 | 13.7 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.7 | 8.6 | GO:0099625 | ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.7 | 5.0 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.7 | 5.8 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.7 | 2.9 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
0.7 | 2.9 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) |
0.7 | 0.7 | GO:0033122 | regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.7 | 4.3 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.7 | 2.1 | GO:2000570 | T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
0.7 | 4.3 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.7 | 1.4 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.7 | 0.7 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
0.7 | 2.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.7 | 14.2 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.7 | 2.8 | GO:0042125 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
0.7 | 2.8 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) glycolytic process from galactose(GO:0061623) |
0.7 | 0.7 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.7 | 2.1 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.7 | 2.1 | GO:0061056 | sclerotome development(GO:0061056) |
0.7 | 0.7 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.7 | 0.7 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
0.7 | 1.4 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.7 | 12.6 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.7 | 1.4 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.7 | 2.8 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.7 | 4.2 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.7 | 5.6 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.7 | 0.7 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.7 | 0.7 | GO:0080144 | amino acid homeostasis(GO:0080144) |
0.7 | 4.2 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
0.7 | 2.8 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.7 | 1.4 | GO:0060065 | uterus development(GO:0060065) |
0.7 | 2.8 | GO:0040030 | regulation of molecular function, epigenetic(GO:0040030) |
0.7 | 2.1 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.7 | 0.7 | GO:1902460 | mesenchymal stem cell proliferation(GO:0097168) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.7 | 1.4 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
0.7 | 5.5 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.7 | 2.7 | GO:0002581 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
0.7 | 2.7 | GO:0030432 | peristalsis(GO:0030432) |
0.7 | 2.0 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.7 | 0.7 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.7 | 2.0 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.7 | 1.4 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.7 | 2.7 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.7 | 2.0 | GO:0007439 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
0.7 | 1.4 | GO:0035666 | TRIF-dependent toll-like receptor signaling pathway(GO:0035666) |
0.7 | 8.1 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.7 | 3.4 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.7 | 0.7 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
0.7 | 2.0 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.7 | 1.3 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.7 | 2.0 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.7 | 1.3 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.7 | 0.7 | GO:1904959 | regulation of electron carrier activity(GO:1904732) regulation of cytochrome-c oxidase activity(GO:1904959) |
0.7 | 1.3 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.7 | 0.7 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
0.7 | 1.3 | GO:0009405 | pathogenesis(GO:0009405) |
0.7 | 2.7 | GO:0051316 | attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation(GO:0051316) |
0.7 | 1.3 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.7 | 2.0 | GO:0032274 | gonadotropin secretion(GO:0032274) |
0.7 | 0.7 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.7 | 1.3 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.7 | 0.7 | GO:0021546 | rhombomere development(GO:0021546) |
0.7 | 0.7 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.7 | 29.8 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.7 | 5.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.7 | 7.2 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.7 | 4.6 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.7 | 4.6 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.7 | 2.6 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.7 | 0.7 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.7 | 1.3 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.7 | 2.0 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.7 | 3.9 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.7 | 4.6 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.6 | 1.3 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.6 | 0.6 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.6 | 0.6 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.6 | 4.5 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.6 | 0.6 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.6 | 4.5 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.6 | 1.3 |